December 07, 2017 Only 29% of groups recently surveyed by research firm PatientView believe pharma has an “excellent” or “good” corporate reputation, the most negative rating in the U.S. since 2013. That compares with 38% of global patient groups that view pharma positively, according to a new U.S.-only breakout report by PatientView. PatientView founder and CEO … Read more
December 05, 2017 Drug companies meet with the EMA to discuss their drugs and development programs throughout the R&D process. The EMA sees such meetings as facilitating the speedy development of safe and effective medicines, leading it to make early, frequent engagement a cornerstone of its initiatives to cut the time it takes to get … Read more
November 30, 2017 John Bell of the University of Oxford wrote the government-commissioned report in consultation with representatives of the life sciences sector. The result is an ambitious list of goals and sketches about how to achieve them. Having worked closely with members of the government while drafting the report, Bell expects most of the … Read more
November 28, 2017 As a result, FDA continually faces the challenges related to building and maintaining a diverse, talented, and dedicated professional workforce. However, we are committed to doing what is necessary to tackle these challenges and maintain a strong FDA — one that attracts and preserves world-class talent. Most recently, I have requested a … Read more
In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management. We greatly appreciate all the work done by NASEM over the past year to produce the comprehensive report released in July, which includes recommendations for the FDA and others on this important issue.
FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks.
Despite blasting pharma for “getting away with murder” on multiple occasions, President Donald Trump is expected to pick a former pharmaceutical executive to lead the Department of Health and Human Services, Bloomberg reports.
The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up the Agency’s plans to speed up the drug regulation process.
Lagging flu vaccination rates in the U.S., especially among children, have scientists working to take the “Ow!” out of immunization. Enter an experimental patch with dissolvable microneedles. A phase 1 study shows that a dissolvable microneedle flu patch is safe and can elicit an immune response as robust as an intramuscular injection.
Martin Shkreli is undisputably weird, but he is not a criminal. That is the essence of his defense attorney’s opening arguments in Shkreli’s securities-fraud trial, which opened in June.